Adverse events at end of · patients with chronic obstructive pulmonary disease
Endobronchial coils leads to higher adverse events at end of compared with control (high certainty).
1 finding from 1 review
Cost‐effectiveness · patients with chronic obstructive pulmonary disease
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
FEV1 % predicted: relative change from baseline · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Mortality at end of · patients with chronic obstructive pulmonary disease
Endobronchial valves showed no clear difference in mortality at end of compared with control (moderate certainty).
1 finding from 1 review
Units of SGRQ change from baseline · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Change from baseline in lung function parameters other than FEV1 · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Meters change from baseline in 6MWD · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Adverse events at end of · patients with chronic obstructive pulmonary disease
Endobronchial valves leads to higher adverse events at end of compared with control (high certainty).
1 finding from 1 review
Cost‐effectiveness · patients with chronic obstructive pulmonary disease
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
FEV1 % predicted: relative change from baseline · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Units of SGRQ change from baseline · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Mortality at end of · patients with chronic obstructive pulmonary disease
Intrabronchial valves showed no clear difference in mortality at end of compared with control (moderate certainty).
1 finding from 1 review
Units of SGRQ change from baseline · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Change from baseline in lung function parameters other than FEV1 · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Meters change from baseline in 6MWD · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Adverse events at end of · patients with chronic obstructive pulmonary disease
Intrabronchial valves leads to higher adverse events at end of compared with control (high certainty).
1 finding from 1 review
Cost‐effectiveness · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
FEV1 % predicted: relative change from baseline · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Mortality at end of · patients with chronic obstructive pulmonary disease
Vapour ablation showed no clear difference in mortality at end of compared with control (low certainty).
1 finding from 1 review
Units of SGRQ change from baseline · patients with chronic obstructive pulmonary disease
1 finding from 1 review